interleukin 1 receptor antagonist
| UniProt | Protein Name |
|---|---|
| P18510 |
|
| GO Term | Evidence Code | PMID |
|---|---|---|
| negative regulation of cytokine-mediated signaling pathway | ||
| inflammatory response to antigenic stimulus |
|
|
| lipid metabolic process | ||
| acute-phase response | ||
| inflammatory response |
| GO Term | Evidence Code | PMID |
|---|---|---|
| plasma membrane | ||
| extracellular exosome |
| GO Term | Evidence Code | PMID |
|---|---|---|
| cytokine activity | ||
| interleukin-1 receptor binding | ||
| interleukin-1, type I receptor binding | ||
| interleukin-1, type II receptor binding | ||
| interleukin-1 receptor antagonist activity |
| InterPro |
|---|
| Cytokine IL1/FGF |
| Interleukin-1 family |
| Interleukin-1 receptor antagonist/Interleukin-36 |
| DO ID | Disease Name | Source |
|---|---|---|
| DOID:0050589 | inflammatory bowel disease | |
| DOID:0050742 | nicotine dependence | |
| DOID:0050854 | Muckle-Wells syndrome | |
| DOID:0060645 | chronic recurrent multifocal osteomyelitis | |
| DOID:0080158 | herpes simplex virus keratitis | |
| DOID:0080652 | calcium oxalate nephrolithiasis | |
| DOID:0080998 | acute necrotizing pancreatitis | |
| DOID:0081120 | Graves ophthalmopathy | |
| DOID:0081267 | graft-versus-host disease | |
| DOID:10126 | keratoconus |
| Species | Gene ID | Alliance of Genome Resources | Orthologous MAtrix |
|---|---|---|---|
| 3557 | ZFIN:ZDB-GENE-040702-2 | ||
| 16181 | RGD:621159 | MOUSE33407 | |
| 27177 | ZFIN:ZDB-GENE-040702-2 | ||
| 60582 | RGD:621159 | RATNO28005 | |
| 403660 | CANLF05125 | ||
| 459501 | PANTR28496 | ||
| 701658 | MACMU08855 | ||
| 780505 | SHEEP13789 | ||
| 100034236 | HORSE09317 | ||
| 100092684 | ORNAN03179 |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
This work is licensed under Creative Commons Attribution 4.0 International
GlyCosmos Portal v4.3.0
Last updated: August 4, 2025